Cargando…

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells

We created a 3D cell co-culture model by combining nanoengineered mesenchymal stem cells (MSCs) with the metastatic breast cancer cell line MDA-MD-231 and primary breast cancer cell line MCF7 to explore the transfer of quantum dots (QDs) to cancer cells. First, the optimal conditions for high-conten...

Descripción completa

Detalles Bibliográficos
Autores principales: Saulite, Liga, Pleiko, Karlis, Popena, Ineta, Dapkute, Dominyka, Rotomskis, Ricardas, Riekstina, Una
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815277/
https://www.ncbi.nlm.nih.gov/pubmed/29515946
http://dx.doi.org/10.3762/bjnano.9.32
_version_ 1783300479077318656
author Saulite, Liga
Pleiko, Karlis
Popena, Ineta
Dapkute, Dominyka
Rotomskis, Ricardas
Riekstina, Una
author_facet Saulite, Liga
Pleiko, Karlis
Popena, Ineta
Dapkute, Dominyka
Rotomskis, Ricardas
Riekstina, Una
author_sort Saulite, Liga
collection PubMed
description We created a 3D cell co-culture model by combining nanoengineered mesenchymal stem cells (MSCs) with the metastatic breast cancer cell line MDA-MD-231 and primary breast cancer cell line MCF7 to explore the transfer of quantum dots (QDs) to cancer cells. First, the optimal conditions for high-content QD loading in MSCs were established. Then, QD uptake in breast cancer cells was assessed after 24 h in a 3D co-culture with nanoengineered MSCs. We found that incubation of MSCs with QDs in a serum-free medium provided the best accumulation results. It was found that 24 h post-labelling QDs were eliminated from MSCs. Our results demonstrate that breast cancer cells efficiently uptake QDs that are released from nanoengineered MSCs in a 3D co-culture. Moreover, the uptake is considerably enhanced in metastatic MDA-MB-231 cells compared with MCF7 primary breast cancer cells. Our findings suggest that nanoengineered MSCs could serve as a vehicle for targeted drug delivery to metastatic cancer.
format Online
Article
Text
id pubmed-5815277
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-58152772018-03-07 Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells Saulite, Liga Pleiko, Karlis Popena, Ineta Dapkute, Dominyka Rotomskis, Ricardas Riekstina, Una Beilstein J Nanotechnol Full Research Paper We created a 3D cell co-culture model by combining nanoengineered mesenchymal stem cells (MSCs) with the metastatic breast cancer cell line MDA-MD-231 and primary breast cancer cell line MCF7 to explore the transfer of quantum dots (QDs) to cancer cells. First, the optimal conditions for high-content QD loading in MSCs were established. Then, QD uptake in breast cancer cells was assessed after 24 h in a 3D co-culture with nanoengineered MSCs. We found that incubation of MSCs with QDs in a serum-free medium provided the best accumulation results. It was found that 24 h post-labelling QDs were eliminated from MSCs. Our results demonstrate that breast cancer cells efficiently uptake QDs that are released from nanoengineered MSCs in a 3D co-culture. Moreover, the uptake is considerably enhanced in metastatic MDA-MB-231 cells compared with MCF7 primary breast cancer cells. Our findings suggest that nanoengineered MSCs could serve as a vehicle for targeted drug delivery to metastatic cancer. Beilstein-Institut 2018-01-29 /pmc/articles/PMC5815277/ /pubmed/29515946 http://dx.doi.org/10.3762/bjnano.9.32 Text en Copyright © 2018, Saulite et al. https://creativecommons.org/licenses/by/4.0https://www.beilstein-journals.org/bjnano/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Nanotechnology terms and conditions: (https://www.beilstein-journals.org/bjnano/terms)
spellingShingle Full Research Paper
Saulite, Liga
Pleiko, Karlis
Popena, Ineta
Dapkute, Dominyka
Rotomskis, Ricardas
Riekstina, Una
Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title_full Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title_fullStr Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title_full_unstemmed Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title_short Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
title_sort nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815277/
https://www.ncbi.nlm.nih.gov/pubmed/29515946
http://dx.doi.org/10.3762/bjnano.9.32
work_keys_str_mv AT sauliteliga nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells
AT pleikokarlis nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells
AT popenaineta nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells
AT dapkutedominyka nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells
AT rotomskisricardas nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells
AT riekstinauna nanoparticledeliverytometastaticbreastcancercellsbynanoengineeredmesenchymalstemcells